A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: Different mechanisms in peritoneal dissemination and hematogenous metastasis
H. Nishimori et al., A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: Different mechanisms in peritoneal dissemination and hematogenous metastasis, JPN J CANC, 91(7), 2000, pp. 715-722
We established a new cell line, AZ-P7a, with high peritoneal-metastatic pot
ential in nude mice. AZ-P7a cells were derived from the human gastric carci
noma line AZ-521, which has low capacity for peritoneal dissemination. AZ-P
7a cells developed peritoneal metastasis in 11/14 (78.6%) mice, whereas the
parental AZ-521 cells developed metastasis in 2/6 (33.3%) mice. The metast
atic foci in the peritoneum showed essentially the same histological appear
ance as those induced by parental cells. The tumorigenicity and the motile
activity of AZ-P7a cells were stronger than those of the parental AZ-521 ce
lls; in contrast, adhesion to the extracellular matrix and the production o
f vascular endothelial growth factor by AZ-P7a cells were decreased. In flu
orescence-activated cell sorter (FACS) analysis, AZ-P7a cells expressed sig
nificantly greater levels of integrins alpha 2, alpha 3, alpha 5, alpha 6 a
nd alpha v beta 5, as compared with AZ-521 cells. However, alpha 1, alpha 4
, alpha v beta 3, hCD44H, hCD44v3, hCD44v6 and hCD44v10 were not expressed
in either cell line. AZ-P7a cells developed no liver metastasis when admini
stered by the intrasplenic injection method, though the highly liver metast
atic cell line AZ-H5c showed the same rate of peritoneal dissemination as t
hat exhibited by AZ-P7a cells after intraabdominal injection. These finding
s suggested that the mechanism of peritoneal dissemination differed from th
at of hematogenous metastasis. Moreover, the latter appears to be controlle
d by more complex mechanisms than the former. Thus, this cell line might be
useful for investigating the mechanism of peritoneal dissemination of huma
n gastric cancer.